Professor Gunnar Keppler Gouras received his Bachelor of Arts and Science in Biology and later his MD degree from Columbia University in 1989. He completed his Neurology residency training at Harvard Medical School in 1995. He also finished his fellowship training in behavioural neurology and dementia at Cornell University Medical College.
Professor Gouras has dedicated a large part of his career to research on Alzheimer’s disease. He did his postdoctoral research training in Neuropathology/Alzheimer’s disease at Johns Hopkins University School of Medicine. He continued his research in Cornell University Medical College and at Rockfeller University, where he worked at the Lab of Molecular & Cellular Neuroscience headed by Paul Greengard, Nobel laureate in 2000. At Rockefeller, he received from the National Institute of Health an NIH KO8 Clinical Scientist Development Award, in 1999.
Until 2011, Professor Gouras was Professor and Head of the Lab of Alzheimer’s disease Neurobiology in the Department of Neurology and Neuroscience at Weill Medical College of Cornell University in New York, USA. Since 2011, he has been living in Sweden, where he is Professor of Neuroscience at the Faculty of Medicine at Lund University. In addition, he also holds the position of leader of the Experimental Dementia Research Unit in the department of Experimental Medical Science at the same university. Since 2012, he is also Head of the Section of Neurobiology and the Coordinator of the Strategic Research Environment in Neuroscience – MultiPark/NeuroLU. He is an Associate Editor for the Neurodegeneration section of the Frontiers in Neuroscience journal and a member of several scientific societies, such as the American Academy of Neurology amd the International Society to Advance Alzheimer Research.
Throughout his career, Professor Gouras has been awarded multiple times for his research on Alzheimer’s disease. He received the Paul Beeson Physician Scholars in Aging Research award (2000) from the American Federation for Aging Research, the Merck Young Investigator Award in Alzheimer’s disease from the American Academy of Neurology (2001), and Temple (2003) and Zenith (2007) awards from the Alzheimer’s Association.